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Tissular Distribution of Argentinean Strains of Bovine Herpesvirus Type 4 
(BoHV-4) in Experimentally-Infected Calves
 Pedro E. Morán1; Sandra E. Pérez1,2;  Jorge P. García1;  Alejandra N. C. Castro1; 
Lucas M. Spetter4; Anselmo C. Odeón3; Andrea E. Verna3,5
Although bovine herpesvirus type 4 (BoHV-4) is primarily associated with reproductive disorders of cattle, it can 
produce a variety of clinical signs. To determine the distribution, the presence and type of microscopic lesions caused 
by BoHV-4 strains of different genotypes an in vivo model, calves were infected with three phylogenetically different 
Argentinean BoHV-4 strains. Samples from nasal and ocular secretions, peripheral blood leukocytes, tissues and 
serum were analyzed. BoHV-4 was isolated from nasal and ocular secretions at 7 and 14 days post-inoculation (dpi). 
Viral DNA was detected by nested PCR in peripheral blood leukocytes at 14 and 21 dpi for two out of three strains 
and in tissues, such as nervous system, trachea, pulmonary and retropharyngeal lymph nodes, spleen and kidney, at 
21 dpi. Antibody levels detected by viral seroneutralization test were mostly low and varied widely for the different 
strains. The tissue distribution of the BoHV-4 strains and the variations observed in the levels of neutralizing anti-
bodies indicate that certain differences can be established among the patterns of biological behavior of each strain. 
This is an initial step to get insight into the biological characteristics of Argentinean BoHV-4 isolates. However, 
further evaluation involving a higher number of inoculated animals will be required to be conclusive on this aspect.
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INTRODUCTION  
Bovine herpesvirus type 4 (BoHV-4) is a member of 
the family Herpesviridae (order Herpesvirales), subfamily 
Gammaherpesvirinae (Lomonte et al. 1996). BoHV-4 has been 
isolated from cattle with respiratory infections, vulvovaginitis, 
mastitis, abortions, endometritis and apparently healthy 
animals throughout the world (Wellemans et al. 1986,  Miyano 
et al. 2004, Izumi et al. 2006, Bilge-Dagalp et al. 2010, 2012). 
This virus has not yet been established as the causal agent of a 
particular disease entity; however, it is primarily associated with 
reproductive disorders of cattle, particularly in the postpartum 
period (Chastant-Maillard 2013). 
Unlike other gammaherpesviruses, BoHV-4 can infect 
a wide range of domestic and wild ruminant species, such as 
American bison (Bison bison), buffaloes, goats, sheep, deer, and 
non-ruminant species like owl monkeys (Aotus trivirgatus), 
lions, domestic cats and rabbits (Kruger et al. 2000, Lin et al. 
2000, Kálmán & Egyed 2005, Dewals et al. 2006). Previous works 
carried on natural- and experimentally-infected animals have 
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shown that BoHV-4 shows an irregular pattern of dissemination 
in bovine tissues (Naeem et al. 1991, Egyed et al. 1996, Asano 
et al. 2003, Fábián et al. 2005, Campos et al. 2014). It has also 
been reported that there are genomic variations among BoHV-
4 isolates from different regions. Emerging strains, whose 
restriction patterns do not fully match to the American (DN599 
and 66-p-347) and European (V test, and Movar LVR140) 
reference strains groups have also been described (Bublot et 
al. 1990, Palmeira et al. 2011). This variability is attributed to 
recombination events among strains and within the same strain, 
mainly in polyrepetitive DNA (prDNA) sequences located on 
both sides of the long unique region (LUR) of the genome, during 
viral replication (Bublot et al. 1991b, Donofrio et al. 2000a, 
Nikolin et al. 2007). In Argentina, this viral agent was virtually 
unknown until its detection and identification in 2007 in samples 
of cervical-vaginal mucus (CVM) from aborted cows (Verna et al. 
2008), by the Specialized Veterinary Diagnostic Service of INTA 
Balcarce. Thereafter, the virus was isolated from nasal swabs, 
lungs, granulosa cells, oocytes (González Altamiranda et al. 2015) 
and bovine semen (Lomónaco et al. 2009, Morán et al. 2013). To 
date, more than 50 isolates have been obtained in our country, 
mainly associated with abortions in bovine females. Genomic 
analyses of these Argentinean strains demonstrated that they are 
highly divergent and can be classified in three different groups: 
Genotype 1 comprises Movar-like strains (European group), 
Genotype 2 includes DN599-like strains (American group) and 
Genotype 3 corresponds to a novel genotype (Verna et al. 2012). 
Considering that there are not previous data about the 
characteristics of the in vivo infection by Argentinean BoHV-
4 strains, the aim of this study was to evaluate the tissue 
distribution, the presence and type of microscopic lesions of 
three phylogenetically different Argentinean BoHV-4 strains, in 
experimentally-infected calves. Information about the biological 
behaviour of this pathogen might contribute to the understanding 
of the pathogenic role of each strain or phylogenetic group in 
cattle.
MATERIALS AND METHODS 
Cell Culture
Madin-Darby Bovine Kidney (MDBK) cells from the 
American Type Culture Collection (ATCC, Rockville, MD, 
USA) were used for this study. MDBK cells were propagated in 
Minimum Essential Medium (MEM) with Earle salts (E-MEM) 
(Sigma-Aldrich, Saint Louis, MO, USA), supplemented with 
10% fetal bovine serum (Bioser, Buenos Aires, Argentina) and 
antibiotic-antimycotic solution (Gibco, Langley, OK, USA). Cells 
were incubated at 37 °C in a 5% CO2 atmosphere.
Virus Strains and Experimental Inoculation of Calves
BoHV-4 strains belonging to different phylogenetic groups 
were selected for the experimental assay. Strains 09/508 (genotype 
1), 08/330 (genotype 2) and 07/435 (genotype 3) (Verna et al. 
2012), displayed distinctive in vitro activity when their biological 
behavior was analyzed in different cell cultures (Verna et al. 2016, 
Morán unpublished results). Viral stocks were propagated in 
MDBK cells, in T-25 flasks (NEST Biotechnology, China) (1 × 105 
cells/ml), for 48 h. Supernatants were harvested and frozen at 
−800C. Virus titres were determined by the endpoint titration 
method and expressed as tissue culture infective doses (TCID50), 
according to Reed & Müench (1938). Four crossbred, male, 6 
month-old calves were used in this study. All animals were free 
of detectable antibodies to BoHV-1. Low neutralizing antibody 
titres to some Argentinean BoHV-4 strains were detected prior 
to animal inoculation. This is a frequent finding even when 
a high number of animals is evaluated (Verna, unpublished 
results). Therefore, calves which were not harboring BoHV-
4 genome in peripheral blood leukocytes, as demonstrated 
by PCR, were selected for this study. Calves were intranasally 
inoculated by aerosolization with 20 ml of 106 TCID50 of BoHV-
4. Ten ml of the inoculum was distributed in each nostril. The 
animals were inoculated as follows: Calf 1 (C1) 09/508 strain, 
Calf 2 (C2) 08/330 strain, Calf 3 (C3) 07/435 strain and Calf 4 
(C4) mock-infected, inoculated with MEM as placebo. Calves 
were maintained in isolated pens and fed on grass hay and 
commercial concentrate foodstuff and water ad libitum. They 
were euthanized at 21 dpi. All animals were monitored daily 
for rectal temperature, presence of nasal and ocular discharges 
and any other clinical sign. Calves were deeply anesthetized 
and euthanized according to the regulations of the Institutional 
Committee for Care and Use of Experimental Animals of INTA 
and the Animal Welfare Committee of the University of the 
Center of Buenos Aires Province (Res. 087/02), Argentina, where 
these experiments were carried out.
Sample Collection
Nasal and ocular secretions, leukocytes from peripheral 
blood and serum samples were collected on 0, 7, 14 and 21 dpi 
for viral genome detection, virus isolation and determination 
of neutralizing antibody titres. At necropsy, on 21 dpi, tissues 
were aseptically and individually collected for virus isolation, 
genome detection and histopathology. The following tissues were 
evaluated: lung, spleen, nasal epithelium, liver, medulla oblongata, 
pulmonary lymph node, tracheal lymph node, palatine tonsil, 
frontal and piriform cerebral lobes, trigeminal ganglia, trachea, 
retropharyngeal lymph node and kidney. Samples were frozen at 
−80 0C or stored in 10% buffered-formalin for histopathology. 
Serology
The presence of neutralizing antibodies was evaluated by 
microtitration (Van Der Maaten et al. 1985) on MDBK cells, in 
96-well plates. The serum samples of the inoculated calves were 
tested with the homologous BoHV-4 and the BoHV-1 reference 
strain Los Angeles. Neutralizing antibody titres were determined 
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as the highest dilution that completely inhibited cytopathic 
effect (CPE) after 72 h of incubation. A three-fold or a higher 
increase in the titre of neutralizing antibodies was considered as 
an indicator of seroconversion due to infection. 
Virus Isolation
Nasal and ocular secretions were diluted (1:5) in MEM 
supplemented with penicillin G (200 U/ml) and streptomycin 
sulfate (200 µg/ml). Tissue samples were homogenized in MEM 
(10% w/v), and the suspensions were centrifuged at 3,000 ×g 
for 30 min at 4 °C. Twenty microliters of supernatant were 
inoculated in quadruplicate into monolayers of MDBK cells in 
96-well plates (NEST Biotechnology, China) and incubated at 
37 °C. Samples were passaged 4 times, 3 days for each passage, 
and monitored daily for CPE. Virus titres in the samples were 
evaluated at the first detection of virus CPE and determined, as 
mentioned above, by the end-point titration method, in 96 well-
plates and expressed as TCID50/ml.
Detection of BoHV-4 DNA by Nested PCR
DNA from tissue samples and peripheral blood leukocytes 
and nasal and ocular secretions was extracted by the phenol 
chloroform method. DNA concentration was determined by 
spectrophotometry in a Nano Drop 2000 (Thermo Scientific-
USA) at an absorbance of 260 nm. 
The presence of BoHV-4 DNA was evaluated by nested 
PCR assay, adapted from Fabian & Egyed (2004), targeting the 
ORF 25 (major capside protein). The PCR amplifications were 
carried out in 25 µl reaction mixture containing 1 µl of 5 mM 
deoxynucleotides triphosphate (Promega), 1µl of each 15 pmol 
primer, 1.25 µl of 50mM MgCl2 ( PB-L, Argentina);  0.25 µl of  5U/
µl Taq DNA polymerase (PB-L, Argentina), 2.5 µl of 10 x buffer 
(PB-L) and water. For the second amplification round, 2 µl of 
the first round PCR product were used. The primers used for the 
amplifications were BoG3 5’GACTATGAGGAATGGCACAAG3’ 
and BoGe 5’TACTCGTAGGCTGGGTCTGG3’ in the first 
round, and B4up 5’GGTTGGAAGTGAGCGTATGAT3’ and 
B4low 5’GTAGGCGGGGTCTGGAAT3’ in the second (Thermo 
Fisher Scientific, Argentina). The PCR products were 737 bp 
and 271 bp for the first and the second round, respectively. 
The amplifications were carried out in a Veriti Thermal Cycler 
(Applied Biosystem - USA) as follows: first round consisted of 94 
oC 15 min.; (94 0C 45 s; 56 0C 45 s; 72 0C 90 s) for 25 cycles. The 
second amplification round was (94 0C 45 s; 56 0C 45 s; 72 0C 60 
s) for 30 cycles and one extension cycle at 72 0C for 10 min.  
DNA from uninfected MDBK cells and PCR mix without 
DNA sample were used as negative controls. DNA from BoHV-4 
12/365-infected MDBK cells was used as positive control. The 
PCR products were separated by electrophoresis in 1.2% agarose 
gels and visualized by SYBR® Safe DNA gel stain (Thermo Fisher 
Scientific, Argentina) under ultraviolet light.
Histopathology
Tissue samples were fixed in 10% neutral buffered formalin, 
paraffin-embedded and stained with hematoxylin and eosin 
(H&E) using routine methods. 
RESULTS
Clinical  Findings 
Clinical signs were not observed in any animals, except for 
mild nasal secretions which were present in C1 at 24 hpi. 
Individual rectal temperatures were recorded. The highest rectal 
temperature (41.7 0C) was recorded at 14 dpi in C2, inoculated 
with strain 08/330.
Isolation of BoHV-4 
BoHV-4 strains 08/330 and 07/435 were isolated from nasal 
secretions at 7 and 14 dpi and the strain 09/508 was isolated at 14 
dpi. Strain 08/330 was isolated from ocular secretions at 7 dpi. The 
identity of all isolates was confirmed by nested PCR. The highest 
virus titres (6.41 and 5.79) were recorded for strain 08/330 in 
nasal and ocular secretions at 7 dpi (Table 1). Nevertheless, in 
comparison with the other strains, isolate 09/508 had a higher 
virus titre in nasal secretion at 14 dpi, the only time point at 
which the virus was isolated. None of the strains were isolated 
from tissues or leukocytes from inoculated or mock-infected 
calves.
Genome Detection
Viral DNA was detected in leukocytes from C1 at 21 dpi 
and C2 at 14 and 21 dpi. As shown in Table 2, viral DNA was 
also detected in spleen, medulla, trigeminal ganglia, trachea 
and piriform cerebral lobe of C1; spleen, trachea, kidney, 
retropharyngeal lymph node, frontal cerebral lobe of C2 and 
from pulmonary lymph node, frontal and piriform cerebral lobes 
of C3. Viral genome was not detected in samples from ocular 
and nasal secretions. As expected, viral DNA was no detected in 
tissues from mock-infected calf. 
Microscopic Findings
At the time of euthanasia, macroscopic lesions were 
not observed in any calf. Microscopic observation of tissues 
revealed mild mononuclear inflammatory response in tracheal 
sub-mucosa and in the capsule of retropharyngeal lymph node 
of obtain basic information on the tissue distribution and the 
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Table 1. Isolation and virus titres (expressed as log10 TCID50/ml) of BoHV-4 from ocular and nasal secretions
Date
dpi
C1 (09/508) C2 (08/330) C3 (07/435) C4
OS NS OS NS OS NS OS NS
0 - - - - - -      -       -
7 - - +5.79 + 6.41 - + 2.36 - -
14 - + 4.05 - + 1.97 - + 2.36 - -
21 - - - - - - - -
OS: ocular secretions, NS: nasal secretions 
Table 2.  Detection of BoHV-4 DNA by nested-PCR and isolation from tissue samples
Tissue Sample C1 (09/508) C2 (08/330) C3  (07/435) C4
PCR Isol PCR Isol PCR Isol PCR Isol
Lung - - - - - - - -
Spleen + - + - - - - -
Nasal epithelium - - - - - - - -
Liver - - - - - - - -
Medulla + - - - - - - -
Pulmonary lymph  node ND ND - - + - - -
Tracheal lymph node - - - - - - - -
Tonsil - - - - - - - -
CNS- frontal lobe - - + - + - - -
Trigeminal ganglia + - - - - - - -
Trachea + - + - - - - -
Retropharyngeal lymph node - - + - - - - -
Kidney - - + - - - - -
CNS - piriform lobe + - - - + - - -
ND: Not done
Table 3.  Antibodies titres to BoHV-4 strains and BoHV-1 determined by VNT
Calf       C1 (09/508)        C2 (08/330)         C3 (07/435)             C4
dpi
Strain
0 7 14 21  0   7 14 21   0 7 14 21   0   7 14 21
08/330 32 32 32 32 64 64 128 128 128 128 128 64 128 128 128 64
07/435 16 16 8 8 4 8 8 16 16 16 8 32 - 8 - 8
09/508 - - 8 32 - 4 4 4 8 8 4 8 - 4 4 4
BoHV1 - - - - - - - - - - - - - - - -
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Figure 1. Microscopic lesions in tissues of BoHV-4.09/508 infected calf (C1) (A) Mononuclear infiltrate in tracheal submucosal (H&E 10x). 
(B) Mononuclear infiltrate in retropharyngeal lymph node capsule (H&E 10x). (C) Mild gliosis and chromatolysis in trigeminal ganglia 
(H&E 40x).
Figure 2. Microscopic lesions in tissues of BoHV-4.07/435 infected calf (C3) (A) Mononuclear infiltrate in the capsular connective of pulmo-
nary lymph node (H&E 10x). (B) Neuronal hyperchromatosis in cerebral frontal lobe (H&E40x). (C) Satellitosis in piriform lobe (H&E 40x).
presence of lesions of field Argentinean BoHV-4 strains in their 
natural host. Even when caution must be taken in reaching 
general conclusions, due to the low number of animals used, 
it is important to highlight that specific organs where the virus 
genome can be detected were identified in this in vivo model and 
slight differences among isolates were observed.   
Viral isolation in cell culture is the gold standard method for 
diagnosis of a virus infection; however, in some circumstances the 
variability in the rate of replication and the presentation of CPE 
of the different viral strains make this methodology laborious 
and difficult to perform. In contrast to other gammaherpesvirus, 
BoHV-4 grows efficiently in cell culture. However, a significant 
variation in the kinetics of replication of different BoHV-4 
isolates has been reported by our research group (Verna et al. 
2016). Although only the strain 08/330 was isolated from ocular 
secretions, all BoHV-4 strains were isolated from nasal secretions 
after inoculation. In agreement with Fábián et al. (2005), isolation 
of BoHV-4 from leukocytes was not demonstrated in this in vivo 
study; nevertheless two out of three infected calves harboring 
viral DNA in leukocytes were detected. None of the strains 
was isolated from tissue samples. Given the complexity of virus 
isolation, the use of highly sensitive techniques, such as nested 
PCR, provides greater efficacy for the detection of the virus.
of C1. Furthermore, mild gliosis, shrunk neurons with pyknotic 
nuclei, eosinophilic cytoplasm and chromatolysis were observed 
in trigeminal ganglia from the same calf (Figure 1). In C3, slight 
mononuclear cell infiltrate was present in the capsular connective 
tissue of the pulmonary lymph node. Neuronal hyperchromatosis 
in the frontal cerebral lobe and mild satellitosis in the piriform 
lobe were also observed (Figure 2). Histological lesions were not 
present in samples from C2 and C4.
Serological Findings
Significant changes in antibody titres were not observed 
when the sera from all calves were tested with the homologous 
strains. As shown in Table 3, seroconversion to the homologous 
strain was only detected in C1 at 21 dpi. Antibody titres at 0 
dpi were detected in calves challenged with strains 08/330 and 
07/435. Nonetheless, it is important to highlight the highest 
neutralizing antibody titres to strain 08/330 detected in all 
animals. Low antibody titres (4 - 32) to 09/508 and 07/435 strains 
were detectable in C2, C3 and C4. Neutralizing antibodies to 
BoHV-1 were not detected.
DISCUSSION AND CONCLUSIONS
Previous studies on BoHV-4 have shown an irregular 
pattern of in vivo replication; the virus replicates in different 
tissues of experimentally-infected animals, both in cattle and 
non-ruminant species (Naeem et al. 1991, Egyed et al. 1996, 
1997, Boerner et al. 1999). The objective of this work was to
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Unlike previous works involving experimentally-infected 
calves (Egyed et al. 1996), clinical signs were not observed in 
the animals inoculated with these Argentinean strains, with the 
exception of a slight nasal discharge in only one calf. While mild 
microscopic lesions in tissues from calves inoculated with the 
strains 09/508 and 07/435 were observed and no microscopic 
findings were present in the tissues of the calf infected with 
the strain 08/330, the PCR results clearly demonstrate that 
these BoHV-4 strains are able to disseminate throughout the 
body, reaching different organs, mainly the respiratory tract. 
Furthermore, it is important to underline that viral DNA from the 
three strains was detected in the central nervous system. While 
these results differ from other experimental inoculations of cattle 
(Egyed et al. 1996, Boerner et al. 1999), they are consistent with 
other previously published reports (Asano et al. 2003, Costa et al. 
2011, Campos et al. 2014). Moreover, the detection of the viral 
genome in spleen agrees with the finding of Lopez et al. (1996), 
regarding the ability of BoHV-4 to produce a persistent infection 
in a particular zone of this organ in cattle.
Although none of the strains were isolated from peripheral 
blood leukocytes, the presence of viral DNA during the second 
and third weeks post-infection confirms that BoHV-4 infects 
and persists in lymphoid cells (Egyed & Bartha 1998, Asano et 
al. 2003, Fábián et al. 2005). It is likely that these cells are in part 
responsible for the tissue distribution of the virus, as it has been 
previously suggested (Egyed et al. 1996). 
Regarding the techniques used to determine the immune 
status of BoHV-4-infected animals, it can be considered that 
VNT results are controversial in the diagnosis of BoHV-4. The 
humoral immune response is not efficient in infected cattle; it 
appears to be associated with a deficient exposure of glycoprotein 
domains involved in the stimulation of viral neutralization 
antibodies production, due to the presence of a barrier of glycans 
(Dubuisson et al. 1990). It has been shown that O-glycosylation 
of the major BoHV-4 glycoprotein gp180 is responsible for hiding 
BoHV-4 vulnerable epitopes (Machiels et al. 2011). BoHV-4 
prevalence is usually low in countries where the virus has been 
detected; seropositivity rates vary in a range of 16 to 30%, with 
low neutralizing antibody titres (1: 8 to 1:64) (Wellemans et al. 
1986, Dubuisson et al. 1989, Wellemberg et al. 1999, Frazier et al. 
2002, Elhassan et al. 2011, Motta Giraldo et al. 2013). Coincident 
with the findings by these authors, low neutralizing antibody 
titres were also detected by VNT in this experiment.
The detection of variable levels of neutralizing antibodies to 
any of the BoHV-4 strains in all animals used in this experiment, 
including the uninfected control calf, makes this finding a point 
of analysis. On the basis of these results it can be hypothesized that 
there could be a non-specific neutralizing factor or cross-reaction 
with other viral agents such as bovine lymphotropic herpesvirus 
(BLHV), another member of the ruminant rhadinovirus group. 
BLHV has also been associated with reproductive failure in cattle 
(Banks et al. 2008, Gagnon et al. 2010) and the genome of this 
virus has been detected in animals with positive serology for 
BoHV-4 (de Boer et al. 2014).
It can also be inferred that this non-specific neutralizing 
activity, present in the serum of animals, could be the reason 
why the virus is completely or partially inhibited and unable 
to develop its pathogenic potential. This could explain the 
presence of mild injuries in infected tissues and the absence 
of severe clinical manifestations. Since VNT can result in the 
detection of non-specific neutralizing action for some strains, 
as mainly observed with strain 08/330, it would be advisable to 
use alternative serological techniques for laboratory diagnosis as 
a tool to survey herds. Currently, a commercial indirect ELISA 
for detection of BoHV-4 antibodies is available. However, the 
possibility of detecting antibodies stimulated by BHLV has also 
been reported and further validation of this test is suggested 
(de Boer et al. (2014). An immunoperoxidase monolayer assay 
(IPMA) for detection of BoHV-4 antibodies has been developed 
by Wellemberg et al. (1999). By this technique it is possible to 
detect antibodies to BoHV-4 earlier than by ELISA. However, 
compared to the ELISA test, IPMA readings are usually subjective 
and need to be interpreted by more than one person to reduce 
subjectivity. 
Overall, the findings of this study suggest that, although 
slight, there are differences in the behavioural patterns of the 
strains used in this in vivo model using the natural host of BoHV-
4. The strain 08/330 was isolated in ocular and nasal secretion, 
showing the highest viral titres when compared with the other 
challenge strains. This data agrees with results of previous in vitro 
experiments, in which it was observed that this strain replicates 
at high titres in different cell lines (Morán unpublished results).
Furthermore, the genome of this strain was detected in 
leukocytes more frequently than the other strains. Virus DNA 
from strains 09/508 and 08/330 was also more frequently detected 
in tissue samples (5/14) whereas the genome of the strain 07/435 
was only detected in 3/14. Nonetheless, despite the differences 
observed in the in vivo activity of BoHV-4 strains and the results 
of cross-neutralizing antibodies among homologues strains, it is 
not possible to establish association between the phylogenetic 
groups and patterns of biological behavior of each strain. Further 
evaluation involving a higher number of inoculated animals will 
be required. Nevertheless, the findings of this study provide 
an initial step to understand the biology of the Argentinean 
isolates of BoHV-4. The high variability among strains isolated 
in Argentina (Verna et al. 2012, 2016) highlights the significance 
of research on the role of this virus as an infectious agent capable 
of causing reproductive disease in cattle. This is the first report in 
Argentina on histopathological findings and tissue distribution 
of BoHV-4 in its natural host after an experimental infection 
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